Annual Shareholders Equity
$2.07 B
-$63.20 M-2.96%
31 December 2023
Summary:
DexCom annual stockholders equity is currently $2.07 billion, with the most recent change of -$63.20 million (-2.96%) on 31 December 2023. During the last 3 years, it has risen by +$242.10 million (+13.25%). DXCM annual shareholders equity is now -2.96% below its all-time high of $2.13 billion, reached on 31 December 2022.DXCM Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$1.98 B
-$455.30 M-18.70%
30 September 2024
Summary:
DexCom quarterly stockholders equity is currently $1.98 billion, with the most recent change of -$455.30 million (-18.70%) on 30 September 2024. Over the past year, it has dropped by -$288.90 million (-12.74%). DXCM quarterly shareholders equity is now -18.70% below its all-time high of $2.43 billion, reached on 30 June 2024.DXCM Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DXCM Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -3.0% | -12.7% |
3 y3 years | +13.3% | -7.3% |
5 y5 years | +211.9% | +158.9% |
DXCM Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -3.0% | +13.3% | -18.7% | +8.5% |
5 y | 5 years | -3.0% | +211.9% | -18.7% | +158.9% |
alltime | all time | -3.0% | +4295.1% | -18.7% | +3721.4% |
DexCom Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $1.98 B(-18.7%) |
June 2024 | - | $2.43 B(+8.3%) |
Mar 2024 | - | $2.25 B(+8.6%) |
Dec 2023 | $2.07 B(-3.0%) | $2.07 B(-8.8%) |
Sept 2023 | - | $2.27 B(+8.0%) |
June 2023 | - | $2.10 B(-5.9%) |
Mar 2023 | - | $2.23 B(+4.7%) |
Dec 2022 | $2.13 B(+4.4%) | $2.13 B(+16.8%) |
Sept 2022 | - | $1.82 B(-19.1%) |
June 2022 | - | $2.26 B(+3.0%) |
Mar 2022 | - | $2.19 B(+7.2%) |
Dec 2021 | $2.04 B(+11.8%) | $2.04 B(-4.4%) |
Sept 2021 | - | $2.14 B(+6.9%) |
June 2021 | - | $2.00 B(+5.0%) |
Mar 2021 | - | $1.90 B(+4.2%) |
Dec 2020 | $1.83 B(+106.9%) | $1.83 B(+21.8%) |
Sept 2020 | - | $1.50 B(+10.7%) |
June 2020 | - | $1.35 B(+44.9%) |
Mar 2020 | - | $934.50 M(+5.9%) |
Dec 2019 | $882.60 M(+33.1%) | $882.60 M(+15.5%) |
Sept 2019 | - | $764.30 M(+11.0%) |
June 2019 | - | $688.30 M(+2.9%) |
Mar 2019 | - | $668.60 M(+0.8%) |
Dec 2018 | $663.30 M(+58.2%) | $663.30 M(+18.0%) |
Sept 2018 | - | $562.20 M(+16.6%) |
June 2018 | - | $482.10 M(+14.3%) |
Mar 2018 | - | $421.70 M(+0.5%) |
Dec 2017 | $419.40 M(+47.8%) | $419.40 M(+9.2%) |
Sept 2017 | - | $384.00 M(+8.6%) |
June 2017 | - | $353.70 M(+27.3%) |
Mar 2017 | - | $277.80 M(-2.1%) |
Dec 2016 | $283.80 M(+28.3%) | $283.80 M(+8.4%) |
Sept 2016 | - | $261.80 M(+6.3%) |
June 2016 | - | $246.40 M(+6.6%) |
Mar 2016 | - | $231.20 M(+4.5%) |
Dec 2015 | $221.20 M(+57.8%) | $221.20 M(+14.4%) |
Sept 2015 | - | $193.30 M(+13.2%) |
June 2015 | - | $170.70 M(+14.9%) |
Mar 2015 | - | $148.60 M(+6.0%) |
Dec 2014 | $140.20 M | $140.20 M(+21.9%) |
Sept 2014 | - | $115.00 M(+15.5%) |
Date | Annual | Quarterly |
---|---|---|
June 2014 | - | $99.60 M(+10.7%) |
Mar 2014 | - | $90.00 M(+7.0%) |
Dec 2013 | $84.10 M(+9.2%) | $84.10 M(+12.6%) |
Sept 2013 | - | $74.70 M(+3.3%) |
June 2013 | - | $72.30 M(-1.8%) |
Mar 2013 | - | $73.60 M(-4.4%) |
Dec 2012 | $77.00 M(-26.3%) | $77.00 M(-4.1%) |
Sept 2012 | - | $80.25 M(-12.1%) |
June 2012 | - | $91.31 M(-8.3%) |
Mar 2012 | - | $99.55 M(-4.7%) |
Dec 2011 | $104.50 M(+71.3%) | $104.50 M(-7.6%) |
Sept 2011 | - | $113.06 M(-7.0%) |
June 2011 | - | $121.58 M(+127.8%) |
Mar 2011 | - | $53.36 M(-12.5%) |
Dec 2010 | $60.99 M(-430.7%) | $60.99 M(+73.1%) |
Sept 2010 | - | $35.24 M(-14.1%) |
June 2010 | - | $41.02 M(-12.2%) |
Mar 2010 | - | $46.73 M(-353.3%) |
Dec 2009 | -$18.45 M(-5.3%) | -$18.45 M(+102.7%) |
Sept 2009 | - | -$9.10 M(-560.3%) |
June 2009 | - | $1.98 M(-87.0%) |
Mar 2009 | - | $15.15 M(-177.8%) |
Dec 2008 | -$19.47 M(-373.6%) | -$19.47 M(-28.7%) |
Sept 2008 | - | -$27.29 M(+85.6%) |
June 2008 | - | -$14.71 M(+408.6%) |
Mar 2008 | - | -$2.89 M(-140.6%) |
Dec 2007 | $7.12 M(-87.5%) | $7.12 M(-58.9%) |
Sept 2007 | - | $17.32 M(-35.1%) |
June 2007 | - | $26.68 M(-26.7%) |
Mar 2007 | - | $36.40 M(-35.9%) |
Dec 2006 | $56.83 M(+15.0%) | $56.83 M(-14.3%) |
Sept 2006 | - | $66.35 M(-14.9%) |
June 2006 | - | $78.01 M(+93.7%) |
Mar 2006 | - | $40.28 M(-18.5%) |
Dec 2005 | $49.41 M(-200.2%) | $49.41 M(-19.2%) |
Sept 2005 | - | $61.12 M(-8.9%) |
June 2005 | - | $67.06 M(-222.7%) |
Mar 2005 | - | -$54.65 M |
Dec 2004 | -$49.31 M(+51.3%) | - |
Dec 2003 | -$32.60 M(+265.1%) | - |
Dec 2001 | -$8.93 M(+179.8%) | - |
Dec 2000 | -$3.19 M | - |
FAQ
- What is DexCom annual stockholders equity?
- What is the all time high annual shareholders equity for DexCom?
- What is DexCom annual shareholders equity year-on-year change?
- What is DexCom quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for DexCom?
- What is DexCom quarterly shareholders equity year-on-year change?
What is DexCom annual stockholders equity?
The current annual shareholders equity of DXCM is $2.07 B
What is the all time high annual shareholders equity for DexCom?
DexCom all-time high annual stockholders equity is $2.13 B
What is DexCom annual shareholders equity year-on-year change?
Over the past year, DXCM annual stockholders equity has changed by -$63.20 M (-2.96%)
What is DexCom quarterly stockholders equity?
The current quarterly shareholders equity of DXCM is $1.98 B
What is the all time high quarterly shareholders equity for DexCom?
DexCom all-time high quarterly stockholders equity is $2.43 B
What is DexCom quarterly shareholders equity year-on-year change?
Over the past year, DXCM quarterly stockholders equity has changed by -$288.90 M (-12.74%)